https://www.avient.com/sites/default/files/2019-12/Fermium_IR_Deck_12.16.19_for_Website.pdf
They use words such as “will,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other
words and terms of similar meaning in connection with any discussion of future operating or financial performance and/or sales.
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to
the Securities and Exchange Commission.
1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures, including adjustments related to
contingent consideration; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; mark-to-market adjustments associated with actuarial gains and losses on pension
and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and
equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-
recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Goldman%2520Sachs%2520Conference%2520-%2520November%25202015.pdf
Slide 1
PolyOne Corporation Page 1
PolyOne Investor Presentation
Goldman Sachs 2015 US Emerging/
SMID Cap Growth Conference
November 2015
PolyOne Corporation Page 2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995.
They use words such as “will,”
“anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with any discussion of
future operating or financial performance and/or sales
You are
advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and
Exchange Commission.
https://www.avient.com/sites/default/files/resources/September%2520Investor%2520Presentation.pdf
They use words such as “will,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other
words and terms of similar meaning in connection with any discussion of future operating or financial performance and/or sales.
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to
the Securities and Exchange Commission.
1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures, including adjustments related to
contingent consideration; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; mark-to-market adjustments associated with actuarial gains and losses on pension
and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and
equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-
recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Seaport%2520Global%2520Transports%2520%2526%2520Industrials%2520Confer....pdf
Investor Day
POLYONE
I N V E S T O R
P R E S E N T A T I O N
M A R C H 2 0 1 8
FORWARD LOOKING STATEMENTS
PolyOne Corporation 2
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements”
within the meaning of the Private Securities Litigation Reform Act of 1995.
They use words such as “will,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other
words and terms of similar meaning in connection with any discussion of future operating or financial performance and/or sales.
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to
the Securities and Exchange Commission.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520RW%2520Baird%25202015%2520Industrial%2520Conference%2520-%2520November%25202015.pdf
PolyOne Corporation Page 1
PolyOne Investor Presentation
RW Baird 2015 Industrial Conference
November 2015
PolyOne Corporation Page 2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995.
They use words such as “will,”
“anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with any discussion of
future operating or financial performance and/or sales
You are
advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and
Exchange Commission.
https://www.avient.com/sites/default/files/2022-03/CESA Nox Product Selector Guide.pdf
POLYMER FAMILY MATERIAL PRODUCT NAME DOSAGE
Polyolefin PEA0820031 CESA Nox PEA0820031 0.5–1%
Polypropylene PPA0820055 CESA Nox PPA0820055 0.5–1%
Polyamide ABA0820029 CESA Nox ABA0820029 0.5–1%
Polyester NBA0820022 CESA Nox NBA0820022 0.5–1%
Polycarbonate NCA0820015 CESA Nox NCA0820015 0.5–2.5%
Styrenic SLA0820009 CESA Nox SLA0820009 0.5–2.5%
TPU RUA0820029 CESA Nox RUA0820029 0.3–1.5%
https://www.avient.com/sites/default/files/2022-03/CESA Release Product Selector Guide.pdf
CESA™ Release Additives
Lubrication
PRODUCT SELECTION GUIDE
CESA RELEASE – STANDARD OFFERINGS
POLYMER FAMILY MATERIAL PRODUCT NAME DOSAGE
Polyolefin PEA0820046 CESA Release PEA0820046 0.5–2.5%
Polypropylene PPA0820053 CESA Release PPA0820053 0.5–2%
Polyamide ABA0820031 CESA Release ABA0820031 1–3%
Polyester NGA0820008 CESA Release NGA0820008 1–2%
Polycarbonate NCA0820014 CESA Release NCA0820014 1–2%
Styrenic SLA0820008 CESA Release SLA0820008 1–5%
TPU RUA0820025 CESA Release 20025 0.5–2%
CESA Release additives can be used in combination with other CESA masterbatches, and formulations can be customized for most applications.
https://www.avient.com/sites/default/files/2022-03/CESA Extend Product Selector Guide.pdf
CESA™ Extend Additives
Chain Extension
CESA EXTEND – STANDARD OFFERINGS
PRODUCT SELECTION GUIDE
POLYMER FAMILY MATERIAL PRODUCT NAME PRODUCT TYPE DOSAGE
Nylon ABA0698501 CESA Extend 78501L Linear 1–6%
Nylon ABA0698502 CESA Extend 78502X Branched 1–6%
Polyester NBA0698490 CESA Extend 58490 Linear 1–6%
Polyester NBA0820023 CESA Extend NBA0820023 Branched 1–6%
Polycarbonate NCA0820004 CESA Extend 90032 Linear 1–6%
Polycarbonate NCA0820005 CESA Extend 90033 Branched 1–6%
TPU RUA0698460 CESA Extend 88460 Linear 1–6%
TPU RUA0698455 CESA Extend 88455 Branched 1–6%
CESA Extend additives can be used in combination with other CESA masterbatches, and formulations can be customized for most applications.
https://www.avient.com/news/polyone-highlights-advanced-healthcare-solutions-medtec-europe-2014
Media Relations Contacts
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for the United Kingdom.pdf
If Seller grants
a discount, such discount only relates to the delivery and/or quantity
of the Products specifically mentioned in Seller’s order
confirmation.
Any such statement, sample or other
information of Seller in relation to the Specifications, the Products
and the use thereof are furnished for the accommodation of Buyer
only and are not warranties or representations of performance
15.
In these Terms, "gross
negligence" shall mean any act or failure to act that seriously and
substantially deviates from a diligence course of action or that is in
reckless disregard of or indifference to the harmful consequence.
16.